VoluMetrix's NIVA|HF for Heart Failure Patients Designated as Breakthrough Device by U.S. FDA
NIVA|HF is an investigational device designed to monitor the venous waveform, a novel physiologic signal, in heart failure patients. As a Breakthrough Device, NIVA|HF will receive pre-market developmental assistance and prioritized regulatory review from FDA. NIVA|HF is the first application of VoluMetrix's proprietary venous waveform technology.
Published: Jun 15, 2021
VoluMetrix Wins Annual BioPitch Competition at BioFlorida Conference 2020
VoluMetrix, a company developing a novel form of vital monitoring (Non-Invasive Venous Waveform Analysis, or NIVA), won the annual “Shark Tank for life sciences” competition, receiving $10,000 in prize funding. VoluMetrix is developing NIVA for a wide range of healthcare applications, including volume status monitoring for heart failure.
Published: Nov 24, 2020
BioFlorida Recognizes Florida's Contribution to Fight COVID-19
VoluMetrix, a company committed to creating a new wave of solutions for vital monitoring to enhance well-being, wins the top recognition in the BioPitch competition at the BioFlorida Inc Annual Conference, where hundreds of industry leaders convened to celebrate and share successes around efforts to test, treat, and prevent COVID-19.
Published: Oct 30, 2020